Concluding statement - neuropharmacological basis and clinical rationale for control of transdermal buprenorphine as a step II analgesic

Henningfield, Jack E.Jack E.HenningfieldWEI-ZEN SUN2018-09-102018-09-102015http://www.sciencedirect.com/science/article/pii/S1875459715000466http://scholars.lib.ntu.edu.tw/handle/123456789/392707Concluding statement - neuropharmacological basis and clinical rationale for control of transdermal buprenorphine as a step II analgesicjournal articlehttp://dx.doi.org/10.1016/j.aat.2015.05.002